The regulators of G protein signaling (RGS) domains of RGS4, RGS10, and GAIP retain GTPase activating protein activity in vitro

por Popov, Serguei, Yu, Kan, Kozasa, Tohru, Wilkie, Thomas M.
Publicado 1997

Feeding and fasting controls liver expression of a regulator of G protein signaling (Rgs16) in periportal hepatocytes

por Huang, Jie, Pashkov, Victor, Kurrasch, Deborah M, Yu, Kan, Gold, Stephen J, Wilkie, Thomas M
Publicado 2006

Malnutrition in Pancreatic Ductal Adenocarcinoma (PDA): Dietary Pancreatic Enzymes Improve Short-Term Health but Stimulate Tumor Growth

por Zolghadri, Yalda, Pal Choudhuri, Shreoshi, Ocal, Ozhan, Layeghi-Ghalehsoukhteh, Somayeh, Berhe, Feaven, Hale, Michael A., Wilkie, Thomas M.
Publicado en Am J Pathol (2018)

The curious case of Gαs gain-of-function in neoplasia

por Innamorati, Giulio, Wilkie, Thomas M., Kantheti, Havish S., Valenti, Maria Teresa, Dalle Carbonare, Luca, Giacomello, Luca, Parenti, Marco, Melisi, Davide, Bassi, Claudio
Publicado en BMC Cancer (2018)

Knockout mouse models reveal the contributions of G protein subunits to complement C5a receptor–mediated chemotaxis

por van den Bos, Esther, Ambrosy, Benjamin, Horsthemke, Markus, Walbaum, Stefan, Bachg, Anne C., Wettschureck, Nina, Innamorati, Giulio, Wilkie, Thomas M., Hanley, Peter J.
Publicado en J Biol Chem (2020)

Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes

por Villasenor, Alethia, Wang, Zhao V., Rivera, Lee B., Ocal, Ozhan, Asterholm, Ingrid Wernstedt, Scherer, Philipp E., Brekken, Rolf A., Cleaver, Ondine, Wilkie, Thomas M.
Publicado 2010

Regulator of G Protein Signaling (RGS16) Inhibits Hepatic Fatty Acid Oxidation in a Carbohydrate Response Element-binding Protein (ChREBP)-dependent Manner

por Pashkov, Victor, Huang, Jie, Parameswara, Vinay K., Kedzierski, Wojciech, Kurrasch, Deborah M., Tall, Gregory G., Esser, Victoria, Gerard, Robert D., Uyeda, Kosaku, Towle, Howard C., Wilkie, Thomas M.
Publicado 2011

Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics

por Layeghi-Ghalehsoukhteh, Somayeh, Pal Choudhuri, Shreoshi, Ocal, Ozhan, Zolghadri, Yalda, Pashkov, Victor, Niederstrasser, Hanspeter, Posner, Bruce A., Kantheti, Havish S., Azevedo-Pouly, Ana C., Huang, Huocong, Girard, Luc, MacDonald, Raymond J., Brekken, Rolf A., Wilkie, Thomas M.
Publicado en Sci Rep (2020)

A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics

por Ocal, Ozhan, Pashkov, Victor, Kollipara, Rahul K., Zolghadri, Yalda, Cruz, Victoria H., Hale, Michael A., Heath, Blake R., Artyukhin, Alex B., Christie, Alana L., Tsoulfas, Pantelis, Lorens, James B., Swift, Galvin H., Brekken, Rolf A., Wilkie, Thomas M.
Publicado en Dis Model Mech (2015)

Gα15 in early onset of pancreatic ductal adenocarcinoma

por Innamorati, Giulio, Wilkie, Thomas M., Malpeli, Giorgio, Paiella, Salvatore, Grasso, Silvia, Rusev, Borislav, Leone, Biagio Eugenio, Valenti, Maria Teresa, Carbonare, Luca dalle, Cheri, Samuele, Giacomazzi, Alice, Zanotto, Marco, Guardini, Vanessa, Deiana, Michela, Zipeto, Donato, Serena, Michela, Parenti, Marco, Guzzi, Francesca, Lawlor, Rita Teresa, Malerba, Giovanni, Mori, Antonio, Malleo, Giuseppe, Giacomello, Luca, Salvia, Roberto, Bassi, Claudio
Publicado en Sci Rep (2021)

The synthetic diazonamide DZ-2384 has distinct effects on microtubule curvature and dynamics without neurotoxicity

por Wieczorek, Michal, Tcherkezian, Joseph, Bernier, Cynthia, Prota, Andrea E., Chaaban, Sami, Rolland, Yannève, Godbout, Claude, Hancock, Mark A., Arezzo, Joseph C., Ocal, Ozhan, Rocha, Cecilia, Olieric, Natacha, Hall, Anita, Ding, Hui, Bramoullé, Alexandre, Annis, Matthew G., Zogopoulos, George, Harran, Patrick G., Wilkie, Thomas M., Brekken, Rolf A., Siegel, Peter M., Steinmetz, Michel O., Shore, Gordon C., Brouhard, Gary J., Roulston, Anne
Publicado en Sci Transl Med (2016)